APA (7th ed.) Citation

S, L., Y, C., M, N., Y, F., & L, Z. (2026). A multidimensional investigation of myelosuppression associated with sintilimab: Integrating pharmacovigilance signal mining with real-world clinical evidence. Frontiers in pharmacology, 17, 1784033. https://doi.org/10.3389/fphar.2026.1784033

Chicago Style (17th ed.) Citation

S, Liu, Chang Y, Nie M, Feng Y, and Zhang L. "A Multidimensional Investigation of Myelosuppression Associated with Sintilimab: Integrating Pharmacovigilance Signal Mining with Real-world Clinical Evidence." Frontiers in Pharmacology 17 (2026): 1784033. https://doi.org/10.3389/fphar.2026.1784033.

MLA (9th ed.) Citation

S, Liu, et al. "A Multidimensional Investigation of Myelosuppression Associated with Sintilimab: Integrating Pharmacovigilance Signal Mining with Real-world Clinical Evidence." Frontiers in Pharmacology, vol. 17, 2026, p. 1784033, https://doi.org/10.3389/fphar.2026.1784033.